This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Oppenheimer's Equity Research Department Announces New Senior Analysts

NEW YORK, April 27, 2011 /PRNewswire/ -- Oppenheimer & Co. Inc. is pleased to announce that it has added new senior analysts in a number of important areas to its research department, including:

Bret Jones, an Executive Director and senior analyst, covering the Healthcare Information Technology & Distribution (HCIT) sector, moved to Oppenheimer from Brean Murray, Carret & Co. where he was recognized in Institutional Investor' s 2010 Analyst poll as Best Up and Comer in the HCIT & Distribution Sector. Bret received a B.S. in Finance from Florida State University and an M.B.A. from Indiana University's Kelley School of Business.

Boris Peaker, an Executive Director and senior analyst, covering the Emerging Biotechnology sector, joins Oppenheimer from Rodman & Renshaw. Boris earned a Ph.D. in Biophysics from Stanford University and a dual B.S. in Physics and Chemistry from SUNY- Stony Brook.

Srinivas Sundararajan, an Executive Director and senior analyst, covering the Specialty Semiconductor and Emerging Technology Sectors, joins us from Barclay's Capital where he was covering the Semiconductor Capital Equipment sector. He holds a B.S./M.S. in Chemical Engineering from the Indian Institute of Technology; a Ph.D. in Chemical Engineering from the University of Mexico and completed post-doctoral work at the University of California at Berkeley.

Tony Tian , an Executive Director and senior analyst, covering the China Industrials sector, joined us from Ladenburg Thalmann. Tony holds a B.S. in Land Management from China Agricultural University, an M.A. in Economics from the University of Connecticut and an M.B.A. in Finance from the Stern School of Business At New York University.

Ingrid Yin , an Executive Director and senior analyst, covering the China Healthcare, Specialty Chemical, and Food & Beverage sectors, also joined us from Brean Murray Carret & Co. Formerly a Senior Research Scientist at Memorial Sloan-Kettering Cancer Center in New York, she holds an M.B.A. from the MIT Sloan School of Management; a Ph.D. in Biochemistry from SUNY - Stony Brook; and a B.S. in Chemistry from Peking University.

Oppenheimer also promoted Brian Bittner , David Ferreiro and Andrew Uerkwitz to Senior Analysts as follows.

Brian Bittner , who covers Restaurants, holds a B.S. in Finance from Indiana University's Kelley School of Business.

David Ferreiro , who covers Life Science Tools and Diagnostics, earned a B.A. in Biology from Middlebury College, and an M.S. and a Ph.D. in Microbiology and Immunology from the Albert Einstein College of Medicine.

Andrew Uerkwitz, who covers Israeli Technology and Diversified Companies, holds a B.S. in Management and Accounting from the University of Massachusetts in Boston and an M.B.A. from the NYU Stern School of Business.

Our new analysts join a team of more than 100 research professionals who cover over 550 companies across seven sectors: China; Consumer & Business Services; Energy; Financials; Healthcare; Industrials; Technology, Media & Telecom.

Oppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange), provides a full range of wealth management, securities brokerage and investment banking services to high-net-worth individuals, families, corporate executives, local governments, businesses and institutions.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs